Amalgamated Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11K Hold
588
﹤0.01% 2407
2025
Q1
$11K Hold
588
﹤0.01% 2339
2024
Q4
$10K Hold
588
﹤0.01% 2443
2024
Q3
$10K Hold
588
﹤0.01% 2473
2024
Q2
$5K Hold
588
﹤0.01% 2796
2024
Q1
$9K Sell
588
-1,677
-74% -$25.7K ﹤0.01% 2497
2023
Q4
$33K Sell
2,265
-175
-7% -$2.55K ﹤0.01% 2424
2023
Q3
$26K Hold
2,440
﹤0.01% 2533
2023
Q2
$31K Buy
2,440
+46
+2% +$584 ﹤0.01% 2516
2023
Q1
$32K Sell
2,394
-362
-13% -$4.84K ﹤0.01% 2481
2022
Q4
$41K Hold
2,756
﹤0.01% 2513
2022
Q3
$33K Buy
2,756
+44
+2% +$527 ﹤0.01% 2640
2022
Q2
$31K Sell
2,712
-70
-3% -$800 ﹤0.01% 2705
2022
Q1
$83K Sell
2,782
-235
-8% -$7.01K ﹤0.01% 2271
2021
Q4
$80K Sell
3,017
-44
-1% -$1.17K ﹤0.01% 2083
2021
Q3
$111K Sell
3,061
-166
-5% -$6.02K ﹤0.01% 2069
2021
Q2
$140K Buy
3,227
+591
+22% +$25.6K ﹤0.01% 2077
2021
Q1
$90K Hold
2,636
﹤0.01% 1558
2020
Q4
$92K Buy
2,636
+8
+0.3% +$279 ﹤0.01% 1531
2020
Q3
$63K Sell
2,628
-60
-2% -$1.44K ﹤0.01% 1443
2020
Q2
$49K Sell
2,688
-269
-9% -$4.9K ﹤0.01% 1450
2020
Q1
$46K Sell
2,957
-14
-0.5% -$218 ﹤0.01% 1578
2019
Q4
$64K Buy
2,971
+24
+0.8% +$517 ﹤0.01% 1775
2019
Q3
$55K Sell
2,947
-24
-0.8% -$448 ﹤0.01% 1704
2019
Q2
$78K Buy
2,971
+414
+16% +$10.9K ﹤0.01% 1713
2019
Q1
$66K Buy
2,557
+88
+4% +$2.27K ﹤0.01% 1629
2018
Q4
$57K Buy
2,469
+1,388
+128% +$32K ﹤0.01% 1557
2018
Q3
$35K Sell
1,081
-1,398
-56% -$45.3K ﹤0.01% 1427
2018
Q2
$70K Buy
2,479
+513
+26% +$14.5K ﹤0.01% 1677
2018
Q1
$70K Sell
1,966
-44
-2% -$1.57K ﹤0.01% 1549
2017
Q4
$78K Buy
2,010
+407
+25% +$15.8K ﹤0.01% 1584
2017
Q3
$41K Buy
1,603
+128
+9% +$3.27K ﹤0.01% 1560
2017
Q2
$40K Buy
1,475
+43
+3% +$1.17K ﹤0.01% 1554
2017
Q1
$47K Buy
1,432
+199
+16% +$6.53K ﹤0.01% 1471
2016
Q4
$29K Buy
+1,233
New +$29K ﹤0.01% 1502